CCA tissues; paracancerous tissues; human umbilical cords; subcutaneous tumors
TFK-1; HuCCT1; HiBEpiC; Hu-MSCs
cell line-derived xenograft
proliferation (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits); EMT (inhibits); stemness (inhibits); ceRNA regulation (other)
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; RNA-seq; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Wound Healing Assay; IHC (Immunohistochemistry); Western Blot; In Vivo Animal Model; Bioinformatics Analysis
potentially acting as a biomarker for CCA diagnosis
circ_0037104 is downregulated in cholangiocarcinoma and is enriched in Hu-MSC-derived exosomes. It suppresses CCA proliferation, migration, invasion, metastasis, EMT, and stemness by sponging miR-620 and regulating the AFAP1/APAF1 axis. The study suggests that Hu-MSC exosomal circ_0037104 may have diagnostic biomarker and therapeutic relevance in CCA.
0.8634
Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1.
combined biological and clinical study